Literature DB >> 6233372

Induction of suppressor T cells by interleukin 2.

C C Ting, S S Yang, M E Hargrove.   

Abstract

The optimal concentration of interleukin 2 (IL 2) for maintaining the in vitro growth of T cells was quite different from that required for the induction of cytotoxic T lymphocytes (CTL) in nu/nu spleen cells. Higher concentrations of IL 2-containing preparations (10 to 30% v/v or 5 to 15 U/ml) were needed to promote the T cell growth, whereas lower concentrations (1 to 3% v/v or 0.5 to 1.5 U/ml) were needed to generate alloreactive CTL. It was further shown that the addition of high concentrations of IL 2 (10 to 30%) suppressed the generation of alloreactive CTL in conventional MLC. High concentrations of IL 2 induced the generation of antigen-nonspecific suppressor T cells in normal spleen cell cultures and augmented the generation of antigen-specific suppressor T cells in MLC. These suppressor cells suppressed the generation of CTL in fresh MLC and in polyclonal CTL cultures. These suppressor T cells could be induced by rat (spleen)-produced, murine (EL-4 cells) produced IL 2 preparations, and a purified human recombinant IL 2 (HR-IL2). The ability to induce suppressor cells correlated with the activity of IL 2 present in these preparations and was independent of their ability to induce cytotoxic effectors. These findings indicate that IL 2 may play a dual role in the regulation of CTL responses. We suggest that during antigen sensitization, the initial endogenous production of lower levels of IL 2 provided the second signal for the differentiation and proliferation of CTL. When higher levels of IL 2 were produced later, the suppressor T cell precursors were activated and differentiated into suppressor effectors to regulate the CTL response.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233372

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  The interleukin 2 gene is expressed in the syncytiotrophoblast of the human placenta.

Authors:  K D Boehm; M F Kelley; J Ilan; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.

Authors:  J P Flexman; L S Manning; B W Robinson
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  Augmentation of the generation of lymphokine-activated killer cells after a single dose of mitomycin C in cancer patients.

Authors:  S Nanbara; S Arinaga; T Akiyoshi
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Phenotypes and spontaneous cell cytotoxicity of mononuclear cells from patients with seronegative spondyloarthropathies: ankylosing spondylitis, psoriatic arthropathy and pauciarticular juvenile chronic arthritis--analysis of mononuclear cells from peripheral blood, synovial fluid and synovial membranes.

Authors:  J Thoen; O Førre; K Waalen; J Pahle
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

5.  Modulation of the IL-2 production defect in vitro in Graves' disease.

Authors:  Z Eisenstein; E Engelsman; M Weiss; Y Kalechman; B Sredni
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  Inhibition of soluble immune response suppressor activity by growth factors.

Authors:  T M Aune
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

7.  The effect of cimetidine on PBL from healthy donors and melanoma patients: augmentation of T cell responses to TCGF mitogens and alloantigens and of TCGF production.

Authors:  A Eisenthal; J Monselise; R Zinger; A Adler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Transfer of spleen cells expanded by T cell growth factor suppresses arthritis induced in rats.

Authors:  H Ogawa; T Tsunematsu
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

9.  Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines.

Authors:  C E Taylor; M B Fauntleroy; P W Stashak; P J Baker
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Production of and response to interleukin-2 in Graves' disease.

Authors:  Z Eisenstein; E Engelsman; M Weiss; Y Kalechman; B Sredni
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.